Stability of a Trivalent Recombinant Protein Vaccine Formulation Against Botulinum Neurotoxin During Storage in Aqueous Solution

Journal of Pharmaceutical Sciences - United States
doi 10.1002/jps.21498
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Development and Evaluation of Candidate Subunit Vaccine Against Botulinum Neurotoxin Serotype B

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2020English

Recombinant Derivatives of Botulinum Neurotoxin a Engineered for Trafficking Studies and Neuronal Delivery

Protein Expression and Purification
Biotechnology
2010English

The Effect of Protein Concentration on the Viscosity of a Recombinant Albumin Solution Formulation

RSC Advances
ChemistryChemical Engineering
2016English

Efficacy of Trivalent, Cold-Adapted, Influenza Virus Vaccine Against Influenza a (Fujian), a Drift Variant, During 2003–2004

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

Botulinum Toxin Complex: A Delivery Vehicle of Botulinum Neurotoxin Traveling Digestive Tract

2012English

Substrate-Based Inhibitors Exhibiting Excellent Protective and Therapeutic Effects Against Botulinum Neurotoxin a Intoxication

Scientific Reports
Multidisciplinary
2015English

Immunoprecipitation of Native Botulinum Neurotoxin Complexes From Clostridium Botulinum Subtype a Strains

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2014English

Stability of Distigmine Bromide in Aqueous Solution

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1970English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy